Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
|
HERS, 1998 | combined estrogen and progestogen | placebo | | Low risk of bias | Negative | NCT00319566 |
Hall, 1998 | combined estrogen and progestogen | placebo | | Exploratory | Negative | |
ERA (estrogen alone ), 2000 | estrogen | placebo | | Exploratory | Negative | NCT00000549 |
EVTET, 2000 | combined estrogen and progestogen | placebo | | Low risk of bias | Negative | |
ERA (estrogen plus medroxyprogesterone), 2000 | combined estrogen and progestogen | placebo | | Exploratory | Negative | NCT00000549 |
EPAT, 2001 | estrogen | placebo | | Exploratory | Negative | |
WEST, 2001 | estrogen | placebo | | Low risk of bias | Negative | |
WAVE, 2002 | combined estrogen and progestogen | placebo | | Exploratory | Negative | NCT00000555 |
Schulman (NHLBI) (estrogen alone), 2002 | estrogen | placebo | | Exploratory | - | NCT00000601 |
ESPRIT, 2002 | estrogen | placebo | | Low risk of bias | Negative | |
WHI, 2002 | combined estrogen and progestogen | placebo | | Low risk of bias | Negative | |
Schulman (NHLBI) (estrogen-progestogen), 2002 | combined estrogen and progestogen | placebo | | | - | NCT00000601 |
WELL-HART (estrogen alone), 2003 | estrogen | placebo | | Exploratory | Negative | NCT00000559 |
WELL-HART (estrogen-progestin), 2003 | combined estrogen and progestogen | placebo | | Exploratory | Negative | NCT00000559 |
EAGAR, 2006 | combined estrogen and progestogen | placebo | | Exploratory | Negative | NCT00000605 |
WHISP, 2006 | combined estrogen and progestogen | placebo | | Exploratory | Negative | |
WISDOM, 2007 | combined estrogen and progestogen | placebo | | Low risk of bias | Negative | ISRCTN63718836 |